PMID- 35011304 OWN - NLM STAT- MEDLINE DCOM- 20220211 LR - 20220211 IS - 1420-3049 (Electronic) IS - 1420-3049 (Linking) VI - 27 IP - 1 DP - 2021 Dec 23 TI - Rosmanol and Carnosol Synergistically Alleviate Rheumatoid Arthritis through Inhibiting TLR4/NF-kappaB/MAPK Pathway. LID - 10.3390/molecules27010078 [doi] LID - 78 AB - Callicarpalongissima has been used as a Yao folk medicine to treat arthritis for years in China, although its active anti-arthritic moieties have not been clarified so far. In this study, two natural phenolic diterpenoids with anti-rheumatoid arthritis (RA) effects, rosmanol and carnosol, isolated from the medicinal plant were reported on for the first time. In type II collagen-induced arthritis DBA/1 mice, both rosmanol (40 mg/kg/d) and carnosol (40 mg/kg/d) alone alleviated the RA symptoms, such as swelling, redness, and synovitis; decreased the arthritis index score; and downregulated the serum pro-inflammatory cytokine levels of interleukin 6 (IL-6), monocyte chemotactic protein 1 (MCP-1), and tumor necrosis factor alpha (TNF-alpha). Additionally, they blocked the activation of the Toll-like receptor 4 (TLR4)/nuclear factor kappaB (NF-kappaB)/c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) pathways. Of particular interest was that when they were used in combination (20 mg/kg/d each), the anti-RA effect and inhibitory activity on the TLR4/NF-kappaB/MAPK pathway were significantly enhanced. The results demonstrated that rosmanol and carnosol synergistically alleviated RA by inhibiting inflammation through regulating the TLR4/NF-kappaB/MAPK pathway, meaning they have the potential to be developed into novel, safe natural combinations for the treatment of RA. FAU - Li, Lianchun AU - Li L AUID- ORCID: 0000-0002-1186-5742 AD - Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin 541006, China. FAU - Pan, Zhenghong AU - Pan Z AD - Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin 541006, China. FAU - Ning, Desheng AU - Ning D AD - Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin 541006, China. FAU - Fu, Yuxia AU - Fu Y AD - Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization, Guangxi Institute of Botany, Chinese Academy of Sciences, Guilin 541006, China. LA - eng GR - 2018GXNSFDA050016/Natural Science Foundation of Guangxi/ GR - 2018GXNSFBA281094/Natural Science Foundation of Guangxi/ GR - ZY20111010/Special Funds for Local Science and Technology Development Guided by the Central Committee/ GR - Guike AA18118015/Guangxi Innovation-driven Development Special Project/ PT - Journal Article DEP - 20211223 PL - Switzerland TA - Molecules JT - Molecules (Basel, Switzerland) JID - 100964009 RN - 0 (Abietanes) RN - 0 (Anti-Inflammatory Agents) RN - 0 (Biomarkers) RN - 0 (Cytokines) RN - 0 (Inflammation Mediators) RN - 0 (NF-kappa B) RN - 0 (Plant Extracts) RN - 0 (Toll-Like Receptor 4) RN - 483O455CKD (carnosol) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) RN - F25TV383OC (rosmanol) SB - IM MH - Abietanes/chemistry/*pharmacology MH - Animals MH - Anti-Inflammatory Agents/*pharmacology MH - Arthritis, Rheumatoid/drug therapy/etiology/*metabolism/pathology MH - Biomarkers MH - Cytokines/blood/metabolism MH - Disease Management MH - Disease Models, Animal MH - Disease Susceptibility MH - Drug Synergism MH - Inflammation Mediators/blood/metabolism MH - Male MH - Mice MH - Molecular Structure MH - NF-kappa B/metabolism MH - Plant Extracts/chemistry/pharmacology MH - Signal Transduction/*drug effects MH - Toll-Like Receptor 4/metabolism MH - p38 Mitogen-Activated Protein Kinases/metabolism PMC - PMC8746366 OTO - NOTNLM OT - Callicarpa longissima OT - TLR4/NF-kappaB/MAPK OT - carnosol OT - rheumatoid arthritis OT - rosmanol OT - synergistic effect COIS- The authors declare no conflict of interest. EDAT- 2022/01/12 06:00 MHDA- 2022/02/12 06:00 PMCR- 2021/12/23 CRDT- 2022/01/11 01:14 PHST- 2021/11/07 00:00 [received] PHST- 2021/12/16 00:00 [revised] PHST- 2021/12/20 00:00 [accepted] PHST- 2022/01/11 01:14 [entrez] PHST- 2022/01/12 06:00 [pubmed] PHST- 2022/02/12 06:00 [medline] PHST- 2021/12/23 00:00 [pmc-release] AID - molecules27010078 [pii] AID - molecules-27-00078 [pii] AID - 10.3390/molecules27010078 [doi] PST - epublish SO - Molecules. 2021 Dec 23;27(1):78. doi: 10.3390/molecules27010078.